CHRS

COHERUS ONCOLOGY INC

CHRS·19249H103·US·Common Stock·Healthcare - Biotechnology-13D/G

CHRS (COHERUS ONCOLOGY INC) is held by 94 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($17.5M), VANGUARD CAPITAL MANAGEMENT LLC ($9.2M), GEODE CAPITAL MANAGEMENT, LLC ($5.3M). Net institutional sentiment: Mixed.

94
Holders
Avg rating(25 Elite)
$72M
Total Value
64% (99)
Fund Consensus
56 buying - 31 selling
CHRSSmart Money Verdict
View all
Held by 94 funds
25 elite
Who's Trading
ActivistTGTimothy G. Youngquist 2020 Irrevocable Trust8.3%May 15, 2026
ActivistTAThomas A. Satterfield, Jr.4.6%Apr 29, 2026
ActivistBlackRock, Inc.BlackRock, Inc.4.9%Apr 27, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
ActivistBIBering Partners II, L.P. ("Bering II")4.1%Nov 4, 2025
InsiderWMWahlstrom MatsSell $74KMay 23, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
10.4M(-1.9%)$17.5M0.0%+2.73%
0
New
5.5M$9.2M0.0%-6.67%
38
Increased
3.1M(+13.7%)$5.3M0.0%-76.59%
31
Increased
2.3M(+4.6%)$3.9M0.0%-49.61%
28
Increased
2.3M(+356.9%)$3.9M0.0%-3.87%
43
New
2.3M$3.8M0.0%-6.67%
37
Increased
1.7M(+104.2%)$2.9M0.0%-44.05%
42
Decreased
1.5M(-9.9%)$2.5M0.0%+29.89%
0
Increased
1.2M(+36.2%)$2M0.0%+7.71%
34
Increased
1.2M(+23.6%)$2M0.0%-75.25%
31
New
949,919$1.6M0.0%-6.67%
35
Increased
913,800(+15.2%)$1.5M0.0%-84.09%
29
Unchanged
899,999$1.5M0.0%+9.22%
0
Increased
696,158(+126.7%)$1.2M0.0%-3.13%
41
New
604,525$1M0.0%-6.67%
35
Decreased
547,209(-10.4%)$924,7830.0%+0.16%
0
Increased
453,763(+492.2%)$766,8590.0%-4.32%
40
Decreased
335,309(-11.8%)$566,6720.0%-44.27%
0
Increased
331,700(+140.5%)$560,5730.0%+2.08%
39
Increased
324,133(+190.2%)$547,7860.0%-3.04%
27

Showing 1-20 of 99

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used